Nanoform Finland Feed

Land	Finland
Lista	First North Finland
Sektor	Hälsovård
Industri	Medicinteknik

2024-04-24 21:50:00 Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines

2024-04-24 17:31:00 Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines

2024-04-16 12:50:00 Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc -2,69% | 0,61 MEUR

2024-04-16 12:40:00 Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024 -2,69% | 0,61 MEUR

2024-04-11 08:00:00 Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan +1,71% | 0,14 MEUR

2024-04-09 08:00:00 Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer +0,78% | 0,23 MEUR

2024-04-08 08:00:00 Nanoform Finland Plc: Certified Adviser change to Carnegie Investment Bank Ab -1,90% | 0,13 MEUR

2024-03-26 18:30:00 The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals +5,42% | 0,26 MEUR

2024-03-12 17:02:00 Nanoform: Notice to the Annual General Meeting of NANOFORM FINLAND Plc -1,41% | 0,39 MEUR

2024-03-12 17:01:00 Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen -1,41% | 0,39 MEUR

2024-03-12 17:00:00 Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 and 1/2020 -1,41% | 0,39 MEUR

2024-03-06 07:30:00 Nanoform Finland Plc - Manager's transactions - Mads Laustsen +1,38% | 0,07 MEUR

2024-03-06 07:30:00 Nanoform Finland Plc - Manager's transactions - Miguel Calado +1,38% | 0,07 MEUR

2024-03-06 07:30:00 Nanoform Finland Plc - Manager's transactions - Jeanne Thoma +1,38% | 0,07 MEUR

2024-03-06 07:30:00 Nanoform Finland Plc - Manager's transactions - Albert Hæggström +1,38% | 0,07 MEUR

2024-02-29 07:11:00 Apalutamide Study Again Demonstrates the Advantages of Nanoforming Over Traditional Cancer Treatment Formulations +0,69% | 0,84 MEUR

2024-02-29 07:10:00 Nanoform: Strong momentum in Project Nanoenzalutamide +0,69% | 0,84 MEUR

2024-02-16 10:00:00 Invitation to Nanoform's Q4 and FY 2023 Report Presentation +1,35% | 0,64 MEUR

2024-02-15 11:45:00 Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines +1,71% | 0,22 MEUR

2024-01-26 10:20:00 Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide +13,59% | 2,64 MEUR

2024-01-10 22:01:00 Nanoform Finland Plc - Manager's transactions - Edward Hæggström +0,55% | 0,21 MEUR

2024-01-10 22:01:00 Nanoform Finland Plc - Manager's transactions - Peter Hänninen +0,55% | 0,21 MEUR

2024-01-10 22:01:00 Nanoform Finland Plc - Manager's transactions - Johanna Kause +0,55% | 0,21 MEUR

2024-01-10 22:01:00 Nanoform Finland Plc - Manager's transactions - Antonio Da Silva +0,55% | 0,21 MEUR

2024-01-10 22:01:00 Nanoform Finland Plc - Manager's transactions - David Rowe +0,55% | 0,21 MEUR

2024-01-10 22:01:00 Nanoform Finland Plc - Manager's transactions - Christian Jones +0,55% | 0,21 MEUR

2024-01-10 22:01:00 Nanoform Finland Plc - Manager's transactions - Albert Hæggström +0,55% | 0,21 MEUR

2024-01-10 22:00:00 The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees +0,55% | 0,21 MEUR

2024-01-05 07:10:00 Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide +3,49% | 0,61 MEUR

2023-12-18 15:00:00 Correction: Share subscriptions based on Nanoform Finland Plc's stock options 1/2020 and 2/2019 -3,14% | 0,18 MEUR

2023-12-05 17:00:00 Share subscriptions based on Nanoform Finland Plc's stock options 1/2019 and 2/2019 -2,16% | 0,05 MEUR

2023-11-29 08:00:00 Nanoform Finland Plc - Manager's transactions - Mads Laustsen +2,73% | 0,66 MEUR

2023-11-29 08:00:00 Nanoform Finland Plc - Manager's transactions - Albert Hæggström +2,73% | 0,66 MEUR

2023-11-29 08:00:00 Nanoform Finland Plc - Manager's transactions - Jeanne Thoma +2,73% | 0,66 MEUR

2023-11-29 08:00:00 Nanoform Finland Plc - Manager's transactions - Miguel Calado +2,73% | 0,66 MEUR

2023-11-22 07:10:00 Nanoform Q3 2023: Nanoformed blockbuster drug enters clinic and another nanoformed drug received FDA orphan designation -5,95% | 0,14 MEUR

2023-11-08 10:00:00 Invitation to Nanoform's Q3 2023 Interim Report +3,11% | 0,05 MEUR

2023-10-23 07:10:00 Nanoform grant Global STARMAP[®] AI License to AstraZeneca +1,90% | 0,18 MEUR

2023-10-19 11:15:00 Nanoformed TargTex oncology drug candidate TTX101 receives FDA Orphan Drug Designation -1,23% | 0,13 MEUR

2023-09-13 16:30:00 Nanoform Finland Plc - Managers' transactions - Johanna Kause -0,49% | 0,04 MEUR

2023-09-13 16:30:00 Nanoform Finland Plc - Managers' transactions - David Rowe -0,49% | 0,04 MEUR

2023-09-13 16:30:00 Nanoform Finland Plc - Managers' transactions - Antonio Da Silva -0,49% | 0,04 MEUR

2023-09-13 16:30:00 Nanoform Finland Plc - Managers' transactions - Peter Hänninen -0,49% | 0,04 MEUR

2023-09-13 16:30:00 Nanoform Finland Plc - Managers' transactions - Christian Jones -0,49% | 0,04 MEUR

2023-09-13 16:30:00 Nanoform Finland Plc - Managers' transactions - Albert Hæggström -0,49% | 0,04 MEUR

2023-09-12 15:30:00 The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees -4,21% | 0,05 MEUR

2023-08-29 17:10:00 Nanoform Finland Plc - Manager's transactions - Mads Laustsen +0,48% | 0,27 MEUR

2023-08-29 17:10:00 Nanoform Finland Plc - Manager's transactions - Miguel Calado +0,48% | 0,27 MEUR

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2025-02-27	Bokslutskommuniké 2024
2024-11-22	Kvartalsrapport 2024-Q3
2024-08-29	Kvartalsrapport 2024-Q2
2024-05-30	Kvartalsrapport 2024-Q1
2024-04-17	Ordinarie utdelning NANOFH 0.00 EUR
2024-04-16	Årsstämma 2024
2024-02-29	Bokslutskommuniké 2023
2023-11-22	Kvartalsrapport 2023-Q3
2023-08-24	Kvartalsrapport 2023-Q2
2023-05-25	Kvartalsrapport 2023-Q1
2023-04-13	Ordinarie utdelning NANOFH 0.00 EUR
2023-04-12	Årsstämma 2023
2023-02-28	Bokslutskommuniké 2022
2022-11-29	Kvartalsrapport 2022-Q3
2022-08-25	Kvartalsrapport 2022-Q2
2022-05-24	Kvartalsrapport 2022-Q1
2022-04-13	Ordinarie utdelning NANOFH 0.00 EUR
2022-04-12	Årsstämma 2022
2022-02-22	Bokslutskommuniké 2021
2021-11-25	Kvartalsrapport 2021-Q3
2021-11-17	Extra Bolagsstämma 2021
2021-08-26	Kvartalsrapport 2021-Q2
2021-05-27	Kvartalsrapport 2021-Q1
2021-04-07	Ordinarie utdelning NANOFH 0.00 EUR
2021-04-06	Årsstämma 2021
2021-02-26	Bokslutskommuniké 2020
2020-11-27	Kvartalsrapport 2020-Q3
2020-09-01	Extra Bolagsstämma 2020
2020-08-28	Kvartalsrapport 2020-Q2

Nanoform Finland

Kalender

Beskrivning

Nanoform Finland

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden